Pulse Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Pulse Biosciences

10/11/2022 22:01

* Pulse Biosciences Inc  PLSE.OQ  reported a quarterly
adjusted
loss of 49 cents​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 45 cents per share.
    * Reported revenue was zero​; analysts expected $200.00
thousand. 
    * Pulse Biosciences Inc's reported EPS for the quarter was a
loss
of 49 cents​.
    * The mean earnings estimate of analysts had fallen by
about 13.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Pulse Biosciences Inc shares had fallen by 20.0% this
quarter and lost 87.6% so far this year.
    * The company reported a quarterly loss of $18.04 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:00 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.45          -0.49          Missed
 Jun. 30 2022      -0.40          -0.44          Missed
 Mar. 31 2022      -0.52          -0.58          Missed
 Dec. 31 2021      -0.51          -0.52          Missed